Rebound COVID-19 after Paxlovid in 2 related family members
On May 24, 2022, the CDC issued a healthcare advisory after reports of COVID-19 symptoms returning (COVID-19 rebound) in certain patients two to eight days after treatment with Paxlovid (Ritonavir-Boosted Nirmatrevir). We described two patients who experienced a rebound of COVID-19 after receiving P...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Conference or Workshop Item |
| Language: | English |
| Published: |
2022
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/102296/13/102296_Rebound%20COVID-19%20after%20Paxlovid%20in%202%20related%20family%20members.pdf http://irep.iium.edu.my/102296/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | On May 24, 2022, the CDC issued a healthcare advisory after reports of COVID-19 symptoms returning (COVID-19 rebound) in certain patients two to eight days after treatment with Paxlovid (Ritonavir-Boosted Nirmatrevir). We described two patients who experienced a rebound of COVID-19 after receiving Paxlovid treatment. |
|---|